Prof. Dr. Toygar Toydemir
He received the title of Professor of General Surgery in 2020. Dr. Toydemir, who has extensive experience in reflux and obesity surgery, continues his work in these fields. You can read the rest of our article about Spatz Gastric Balloon prices, treatment process, and post-treatment precautions.
Read More Make an AppointmentSpatz3 Adjustable Intragastric Balloon (AIGB) attracts attention as a non-surgical, innovative method in obesity treatment. This silicone device, placed endoscopically into the stomach and filled with saline, increases the feeling of satiety and reduces food intake. Thanks to its unique adjustable feature, the balloon volume can be increased or decreased as needed during weight loss processes. This helps overcome weight loss plateaus and also relieves intolerance symptoms. Clinical studies confirm its effective results; for example, a 45.7% excess weight loss was reported in 12 months. Spatz3 AIGB prioritizes patient safety and comfort to provide successful weight management.
The Spatz Adjustable Intragastric Balloon (AIGB) is a major milestone in the field of bariatric endoscopy. Its development process aimed to overcome the limitations of previous intragastric balloons (IGB). The history of the Spatz Balloon extends from the early development processes of intragastric balloons in the 1980s to today’s innovative adjustable balloon technology.
Emergence of the First Intragastric Balloons:
The fundamental idea behind intragastric balloons is to create a feeling of satiety by occupying space in the stomach. The Garren-Edwards gastric balloon, introduced in 1985, was one of the first FDA-approved devices in this field. However, it was withdrawn from the market due to complications (such as gastric ulcers and erosions). During this period, new balloon designs filled with fluid and air were developed, but these devices typically faced problems like a limited six-month usage period and balloon migration. Patients also frequently struggled to tolerate these balloons.
Development of the Spatz Adjustable Balloon:
The Spatz Adjustable Balloon was designed to overcome these limitations. It represents an innovative approach in intragastric balloon technology. Due to its unique adjustability, the balloon volume can be changed during the implantation period (up to 12 months). Volume increases provide an effective solution for overcoming weight loss plateaus, while volume decreases can be used to alleviate intolerance symptoms. Additionally, the silicone-coated anchor system and internal chain design address problems such as balloon migration, which were frequently observed in previous models.
Clinical Evaluations and Outcomes:
Clinical studies support the effectiveness of the Spatz Balloon. In a study conducted on patients with an average BMI of 36.6, a mean of 45.7% excess weight loss (EWL) was reported at the end of 12 months. These results reveal that the Spatz Balloon is a non-surgical, effective option in obesity treatment.
The Spatz3 Adjustable Intragastric Balloon (AIGB) offers an effective option for adult individuals seeking medical support in the fight against obesity and who meet certain criteria. This device can be used especially in patients 18 years and older with a Body Mass Index (BMI) between 27–40 kg/m². Spatz3 AIGB is only suitable for individuals who have not succeeded in losing weight through supervised weight management programs.
By placing this balloon in the stomach, it increases the feeling of satiety and reduces food intake. The device’s maximum usage period is twelve months, providing patients with the chance to achieve sustainable weight loss during this time. However, its effectiveness increases when combined with long-term diet and behavioral modification programs. Therefore, it is important for candidates to be prepared and determined for such a lifestyle change.
Although the Spatz3 Adjustable Intragastric Balloon (AIGB) is an effective method in obesity management, it is not suitable for everyone. Certain health conditions may jeopardize the safety or effectiveness of the procedure. Firstly, individuals who have previously undergone surgical procedures on the stomach, esophagus, or duodenum are not suitable for balloon placement due to anatomical changes. Such situations increase the risk of complications.
Active inflammatory gastrointestinal diseases, such as esophagitis, Crohn’s disease, or peptic ulcers, also contraindicate this procedure. Placing the balloon under these conditions may increase inflammation or bleeding risks. Similarly, people at risk of gastrointestinal bleeding (e.g., varices or intestinal telangiectasias) may face serious bleeding risks if a balloon is placed.
Structural anomalies such as strictures or diverticula in the esophagus can prevent the safe placement of the balloon. Additionally, individuals with severe esophageal motility disorders (e.g., achalasia) have an increased risk of complications during balloon removal.
Uncontrolled diabetes, severe liver disease (cirrhosis, liver failure), and chronic abdominal pain or motility disorders such as gastroparesis are significant obstacles to the procedure. These conditions create risks regarding side effects the balloon may cause or worsening of existing symptoms.
Women who are pregnant or breastfeeding are not suitable candidates for the Spatz3 AIGB. Moreover, individuals with uncontrolled psychiatric disorders or active alcohol or substance abuse are also not suitable for this treatment. These conditions can prevent adherence to the necessary lifestyle changes and reduce treatment effectiveness.
The Spatz3 Adjustable Intragastric Balloon (AIGB) procedure is carried out by an expert team, prioritizing the patient’s safety and comfort. The process consists of a series of careful preparations and meticulous application steps.
Preparation Process:
Patients are required to fast for at least 12 hours before the procedure. This is to reduce the risk of aspiration of stomach contents and increase the success of the endoscopic procedure. On the day of the procedure, an IV line is opened, and sedatives are administered. Vital signs are monitored continuously throughout the procedure.
Sedation:
Conscious or deep sedation is chosen during the procedure for patient comfort and safety. Drugs such as midazolam and fentanyl help the patient relax while ensuring the continuation of protective reflexes. An anesthesiologist or trained specialist closely monitors sedation levels.
Endoscopic Examination:
Before balloon placement, the upper gastrointestinal system is examined by endoscopy. This allows for the detection of stomach ulcers, erosions, or other issues that could hinder balloon placement. If such a problem is found, the procedure may be postponed.
Placement and Inflation of the Balloon:
Once the stomach is deemed suitable, the balloon is placed into it before inflation. Sterile saline is used for inflation, and the volume is determined between 400–550 ml based on the patient’s anatomy. Thanks to the adjustable feature of Spatz3, the balloon volume can be modified later if needed.
Post-Procedure Monitoring:
After the procedure, patients are kept under observation until the sedative effect wears off. Vital signs are monitored for any emergencies. Patients are informed about severe pain, vomiting, or bleeding.
Balloon Removal:
After twelve months of use, the balloon is carefully removed endoscopically. During removal, the stomach tissue is examined for potential complications. The Spatz3 balloon provides a non-surgical solution offering safe and effective weight management.
Although the Spatz Gastric Balloon is used as an effective method in obesity treatment, various side effects and potential complications may occur. Common side effects generally arise in the early phase of treatment and are mostly temporary. During the first few days following balloon placement, gastrointestinal discomfort is common. Such discomfort may include abdominal pain, cramping, nausea, vomiting, bloating, and belching. Most patients find that these symptoms lessen within a week. Antiemetic and antispasmodic medications may be prescribed to provide relief.
Gastroesophageal Reflux Disease (GERD) is also frequently seen during balloon treatment. Acid reflux may increase, causing heartburn. These symptoms can generally be controlled with proton pump inhibitors and antacids.
Less commonly, complications such as gastric ulceration and erosion may develop. The balloon may irritate the stomach lining, resulting in ulcers. Regular doctor check-ups are important for the early detection and treatment of such complications.
More rare but severe complications include balloon deflation and migration, gastric perforation, intestinal obstruction, esophagitis, and acute pancreatitis. These conditions can lead to serious medical emergencies, often requiring surgical intervention.
The Spatz3 Adjustable Gastric Balloon (AGB) stands out as a powerful option in obesity treatment, offering higher success rates compared to traditional gastric balloons. Clinical studies show that an impressive 84% of patients achieve significant weight loss using Spatz3 AGB. “Significant weight loss” is defined as losing more than 10% of total body weight or 25% of excess weight. Considering that the success rates for non-adjustable balloons range between 25% and 48%, the effectiveness of Spatz3 AGB is evident.
The unique adjustability of Spatz3 AGB underlies its success. This feature allows for changes in balloon volume during treatment. For instance, in patients who develop intolerance symptoms, the balloon volume can be reduced to alleviate discomfort. Conversely, if weight loss stalls, an increase in volume can help overcome the plateau. This flexibility not only increases patient tolerance but also ensures a more sustainable weight loss process.
The treatment outcomes are quite remarkable. With Spatz3 AGB, the average total body weight loss (TBWL) is 14.9%, while the excess weight loss (EWL) is 52.9%. Compared to non-adjustable balloons—which achieve 6.6%–10.2% TBWL and 24.1%–38% EWL—these figures are substantially higher. Additionally, the 12-month implantation period of Spatz3 AGB gives patients sufficient time to develop healthy habits and achieve long-term weight loss.
Undergoing Spatz gastric balloon placement is an important step toward successful weight loss and a healthier lifestyle. However, adequate preparation for this procedure is vital to improve both the effectiveness and safety of the outcome. First, a comprehensive medical evaluation is conducted, including health history, current condition, laboratory tests, and physical examinations. Imaging techniques and endoscopic examinations of the stomach and surrounding organs are also performed to identify any conditions that may hinder balloon placement.
Psychological preparation is another critical stage. This step ensures you are prepared to adopt lifestyle changes after the procedure. Your eating habits, level of motivation, and mental health status are assessed to determine if you can adapt to a new dietary routine and physical activities.
Nutritional counseling and medication adjustments are also part of the preparation process. A liquid diet before the procedure prepares the stomach and reduces the risk of complications. While some medications may be temporarily discontinued, proton pump inhibitors may be used to control stomach acid.
Finally, educational and logistical planning steps take place, which include detailed information about the procedure, potential risks, and lifestyle changes.
The success of Spatz3 Adjustable Intragastric Balloon (AIGB) treatment depends not only on placing the balloon but also significantly on the care process thereafter. In the first few days, patients may experience symptoms such as nausea, vomiting, abdominal pain, and reflux. These symptoms can be managed with antiemetics, proton pump inhibitors (PPIs), and analgesics under a doctor’s supervision. The symptoms typically subside within a few days.
The dietary transition plays a critical role in treatment success. Only liquids should be consumed for the first 3–5 days, followed by puréed foods for about a week. After that, patients gradually progress to soft solids and, ultimately, a balanced normal diet. Eating slowly, chewing thoroughly, and practicing portion control are essential. This approach prevents stomach discomfort and supports weight loss.
Lifestyle changes complement balloon treatment. Regular physical activity, cognitive behavioral therapy, and mindful eating habits are necessary for long-term success. It is important for patients to identify their emotional eating triggers and learn how to manage these behaviors.
Regular doctor check-ups are mandatory during the treatment process. During these visits, balloon volume can be adjusted as needed to address weight loss or tolerance issues. After the balloon is removed, maintaining healthy habits is essential for permanent weight control.
How does the Spatz gastric balloon differ from other gastric balloons?
Unlike other gastric balloons, which have a fixed volume, the Spatz3 balloon can have its volume adjusted after placement and has a longer duration of use. While other balloons remain in place for about 6 months, the Spatz3 balloon can stay up to 12 months, allowing patients more time to make sustainable lifestyle changes and achieve greater weight loss. Clinical research indicates that the Spatz3 balloon facilitates an average 15–20% weight loss, whereas other balloons generally result in around 10–15%.
How does the adjustable feature impact the treatment process?
The unique adjustability of the Spatz3 Adjustable Gastric Balloon improves the treatment process by allowing volume changes according to the patient’s needs. This feature provides a 12-month implantation period, and adjustable balloons offer better weight loss outcomes based on these adjustments. Clinical studies show that patients achieve an average of 15–16.4% total body weight loss, with excess weight loss (EWL) ranging from 45.7% to 67.4%. Adjusting the balloon volume relieves early intolerance by 80% and can provide an additional 5.7 kg of weight loss after upward adjustments to overcome plateaus. Such adjustments help 88.5% of patients reach significant weight loss goals. Moreover, the Spatz3 balloon’s 84% success rate surpasses the 25–48% success rates of other gastric balloons.
How many months can this balloon remain in the stomach?
Once placed in the stomach, the Spatz Gastric Balloon can stay for up to 12 months. This duration is longer than most other gastric balloons, giving patients more time to implement the lifestyle changes necessary for weight loss.
Are lifestyle changes necessary after the Spatz gastric balloon is removed?
Yes, to achieve permanent weight loss, long-term lifestyle changes are important once the Spatz gastric balloon is removed. While the balloon helps with portion control and healthy eating habits during its placement, maintaining these habits afterward is crucial. Patients are advised to follow a balanced diet, engage in regular exercise, and participate in behavior modification programs for lasting weight management.
Is there pain or discomfort during balloon placement?
Some mild discomfort may be felt during the endoscopic placement of the Spatz gastric balloon. After the procedure, most patients experience side effects such as nausea (about 90%), vomiting (72%), abdominal pain (60%), bloating, and belching during the first few days. These symptoms are usually temporary and can be managed with medication. Balloon volume adjustment may reduce discomfort for some patients. Severe complications are rare, but proper treatment and follow-up can ease the process.
References
Prof. Dr. Toygar Toydemir - Uncategorized - Stomach Botox Cost : With and without insuranceGastric [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Gastric Balloon Cost : With and without insuranceThe [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Gastric Bypass Surgery Cost : With and without [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Gastric Sleeve Surgery Cost : With and without [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Reflux Surgery Cost: With and without insuranceReflux surgery [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Cost of gallbladder surgery: With and without insuranceGallbladder [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Postoperative PeriodYour new life starts here… The postoperative [...]
Prof. Dr. Toygar Toydemir - Uncategorized - Preoperative PeriodObesity is a condition that physically and [...]
Deutsch
Türkçe
Български